Clinical Trial Update: Arginase Inhibition in Type 1 and Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

This entry reports the completion of a clinical trial evaluating an arginase inhibitor for Type 1 and Type 2 diabetes conducted by Karolinska Institutet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Arginase inhibitor

Snippet

Sponsor: Karolinska Institutet | Conditions: Type 1 Diabetes, Type 2 Diabetes | NA | Status: COMPLETED